WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Philips Clinical & Medical Affairs Global
Study ID
NCT04701684
Status
Recruiting
Apply to this trial

Conditions

  • Stroke, Acute

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Direct to Angio Suite (DTAS) Philips' CBCT triage — DEVICE
    Stroke patients are diagnosed and treated (mechanical thrombectomy) in the same angio suite
  • Conventional CT/MR triage — PROCEDURE
    First a CT or MRI exam is acquired for triage. In case of an ischemic stroke the patient is then treated in an interventional suite.

Study Details

The WE-TRUST study is a multi-center randomized clinical trial to assess the impact of a Direct to Angio Suite (DTAS) workflow on stroke patient outcomes.

Key Dates

Start date
Jun 23, 2021
Status verified
Mar 2026
Primary completion
Apr 1, 2027
Completion
Apr 1, 2027

Study Design

Enrollment
594 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Direct tot Angiography Suite (DTAS) triage workflow
  • Active Comparator: Conventional CT/MR triage workflow

Primary Outcome Measure

Distribution of ordinal modified Rankin Scale (mRS) scores at 90 ± 14 days follow-up [ Time Frame: 90 ± 14 days follow-up ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Baptist Medical CenterJacksonvilleFlorida32207
Ricardo Hanel
Grady Memorial Hospital/Emory UniversityAtlantaGeorgia30303
Diogo Haussen
Raul Nogueira
Montefiore Medical CenterThe BronxNew York10467
Seon Kyu Lee

Find similar trials in Jacksonville, FL

By research site
Baptist Medical Center· Jacksonville, FLGrady Memorial Hospital/Emory University· Atlanta, GAMontefiore Medical Center· The Bronx, NY

Related Studies